Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo

YA-DONG DONG; Long Cui; CHENG-HONG PENG; DONG-FENG CHENG; BAO-SAN HAN; Fang Huang

doi:10.3892/or.2012.2070

journal article Oct 04, 2012

Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo

YA-DONG DONG Long Cui

CHENG-HONG PENG DONG-FENG CHENG BAO-SAN HAN Fang Huang

Oncology Reports Vol. 29 No. 1 pp. 87-94 · Spandidos Publications

View at Publisher Save 10.3892/or.2012.2070

Topics

No keywords indexed for this article. Browse by subject →

References

31

[1]

Jemal "Global cancer statistics" CA Cancer J Clin (2011) 10.3322/caac.20107

[2]

Ferlay "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008" Int J Cancer (2010) 10.1002/ijc.25516

[3]

Tajima "Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background" Clin Cancer Res (2006) 10.1158/1078-0432.ccr-06-1339

[4]

HMGB1 and RAGE in Inflammation and Cancer

Gary P. Sims, Daniel C. Rowe, Svend T. Rietdijk et al.

Annual Review of Immunology 2010 10.1146/annurev.immunol.021908.132603

[5]

Okada "Novel complementary peptides to target molecules" Anticancer Res (2011)

[6]

Takahata "Postoperative serum concentrations of high mobility group box chromosomal protein-1 correlates to the duration of SIRS and pulmonary dysfunction following gastrointestinal surgery" J Surg Res (2011) 10.1016/j.jss.2011.04.040

[7]

Naglova "HMGB1 and its physiological and pathological roles" Bratisl Lek Listy (2012)

[8]

Lee "Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function" J Proteome Res (2010) 10.1021/pr100386r

[9]

Tang "High-mobility group box 1 and cancer" Biochim Biophys Acta (2010) 10.1016/j.bbagrm.2009.11.014

[10]

Kostova "The expression of HMGB1 protein and its receptor RAGE in human malignant tumors" Mol Cell Biochem (2010) 10.1007/s11010-009-0305-0

[11]

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma

D Wu, Y DING, S Wang et al.

The Journal of Pathology 2008 10.1002/path.2391

[12]

Chung "Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer" J Transl Med (2009) 10.1186/1479-5876-7-38

[13]

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

Yong Liu, Congliang Xie, Xin Zhang et al.

European Journal of Cancer 2010 10.1016/j.ejca.2010.07.016

[14]

Choi "Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line" Tumori (2011) 10.1177/030089161109700211

[15]

Moriwaka "HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer" Pathobiology (2010) 10.1159/000272950

[16]

Luo "HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer" Eur J Cancer (2010) 10.1016/j.ejca.2009.11.011

[17]

Yan "High mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases" Hepatology (2012) 10.1002/hep.25572

[18]

Tafani "Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B" Carcinogenesis (2011) 10.1093/carcin/bgr101

[19]

Chen "Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference" J Cell Physiol (2012) 10.1002/jcp.24069

[20]

Jiang "Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3" Dig Dis Sci (2012) 10.1007/s10620-011-1944-z

[21]

Hallmarks of Cancer: The Next Generation

Douglas Hanahan, Robert A. Weinberg

Cell 2011 10.1016/j.cell.2011.02.013

[22]

Lin "Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma" J Cancer Res Clin Oncol (2012) 10.1007/s00432-011-1067-0

[23]

Ohmori "Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer" Expert Opin Ther Targets (2011) 10.1517/14728222.2011.546785

[24]

Peng "Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer" BMC Cancer (2010) 10.1186/1471-2407-10-496

[25]

HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer

Clarissa A. Wild, Sven Brandau, Ramin Lotfi et al.

Oral Oncology 2012 10.1016/j.oraloncology.2011.12.009

[26]

Cheng "Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma" Dig Liver Dis (2008) 10.1016/j.dld.2007.11.024

[27]

Liang "Ethyl pyruvate administration inhibits hepatic tumor growth" J Leukoc Biol (2009) 10.1189/jlb.0908578

[28]

Czyzewska "Evaluation of proliferating markers Ki-67, PCNA in gastric cancers" Rocz Akad Med Bialymst (2004)

[29]

Cawston "Understanding the role of tissue degrading enzymes and their inhibitors in development and disease" Best Pract Res Clin Rheumatol (2006) 10.1016/j.berh.2006.06.007

[30]

Phosphorylated Akt/PKB Controls Cell Growth and Apoptosis in Intraductal Papillary–Mucinous Tumor and Invasive Ductal Adenocarcinoma of the Pancreas

Shuho Semba, Toshiyuki Moriya, Wataru Kimura et al.

Pancreas 2003 10.1097/00006676-200304000-00008

[31]

Zhang "Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo" Technol Cancer Res Treat (2009) 10.1177/153303460900800608

Metrics

51

Citations

31

References

Details

Published: Oct 04, 2012
Vol/Issue: 29(1)
Pages: 87-94

Authors

*Medical Research Council Centre for Protein Engineering, Hills Road, Cambridge CB2 2QH, United Kingdom;

Cite This Article

YA-DONG DONG, Long Cui, CHENG-HONG PENG, et al. (2012). Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo. Oncology Reports, 29(1), 87-94. https://doi.org/10.3892/or.2012.2070

Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo

You May Also Like